Multiple Sclerosis Trial, Recruiting NCT06919900 Sponsor: Georgia State University Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, Recruiting

NCT06919900
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with multiple sclerosis (MS)
  • People who are at least 45 years old
  • People who are able to walk at least 25 feet (roughly 7-8 metres) on their own, without help
  • People who are able to stand on their own for at least 30 seconds
  • People whose MS-related disability falls within a certain range, as measured by a specific scoring tool called the Patient Determined Disability Steps scale (a score between 0 and 4)
  • People who are not currently pregnant
  • People who score 23 or higher on a standard memory and thinking assessment called the Montreal Cognitive Assessment

Who may not be able to join:

  • People who have previously taken part in perturbation training (a type of balance training that involves controlled pushes or surface movements — confirm with trial site if unsure)
  • People whose bone density scan (a DXA scan) shows a T-score below -2.5, which may indicate low bone density
  • People who have a psychiatric condition, another neurological condition, a serious medical illness, or a cardiovascular (heart or blood vessel) disease
  • People who have experienced an MS relapse (a flare-up of symptoms) within the past 8 weeks

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 404-413-8357

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Georgia State University
Registry
ClinicalTrials.gov
Start date
6 April 2026
Est. completion
1 March 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Perturbation Outcome (Fall or Non-Fall) on the Treadmill or Overground

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov